Abstract
The pathology chapter in this text is primarily aimed at presenting pertinent diagnostic information to the oncologic management of patients with salivary gland malignancies. Therefore, detailed descriptions of cytomorphologic features of individual entities are briefly presented and lineage-related markers used in differential diagnosis of certain subtypes are highlighted. The role and utilization of fine needle aspiration technology in early classification, differential diagnosis, and follow-up are addressed in the context of their relevance to surgical planning, confirmation of progression and biomarker studies. Current and emerging genetic findings and their potential diagnostic and management implications are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Batsakis JG, Luna MA, El-Naggar AK. Histopathologic grading of salivary gland neoplasms: II. Acinic cell carcinomas. Ann Otol Rhinol Laryngol. 1990;99(11):929–33.
Ianez RF, et al. Human salivary gland morphogenesis: myoepithelial cell maturation assessed by immunohistochemical markers. Histopathology. 2010;57(3):410–7.
Bilgin CC, et al. Multiscale feature analysis of salivary gland branching morphogenesis. PLoS One. 2012;7(3):e32906.
Knox SM, et al. Parasympathetic innervation maintains epithelial progenitor cells during salivary organogenesis. Science. 2010;329(5999):1645–7.
Batsakis JG, et al. Histogenesis of salivary gland neoplasms: a postulate with prognostic implications. J Laryngol Otol. 1989;103(10):939–44.
Klijanienko J, Vielh P. Fine-needle sampling of salivary gland lesions. IV. Review of 50 cases of mucoepidermoid carcinoma with histologic correlation. Diagn Cytopathol. 1997;17(2):92–8.
Klijanienko J, Vielh P. Fine-needle sampling of salivary gland lesions. III. Cytologic and histologic correlation of 75 cases of adenoid cystic carcinoma: review and experience at the Institut Curie with emphasis on cytologic pitfalls. Diagn Cytopathol. 1997;17(1):36–41.
Sivars L, et al. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome. Cancer Med. 2014;3(2):376–84.
Strojan P, et al. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck. 2013;35(2):286–93.
Klijanienko J, Vielh P. Salivary carcinomas with papillae: cytology and histology analysis of polymorphous low-grade adenocarcinoma and papillary cystadenocarcinoma. Diagn Cytopathol. 1998;19(4):244–9.
Kawahara A, et al. Salivary duct carcinoma cytologically diagnosed distinctly from salivary gland carcinomas with squamous differentiation. Diagn Cytopathol. 2008;36(7):485–93.
Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986;8(3):177–84.
Skalova A, et al. Pleomorphic adenoma of the salivary glands with intravascular tumor deposits: a diagnostic pitfall. Am J Surg Pathol. 2012;36(11):1674–82.
Knight J, Ratnasingham K. Metastasising pleomorphic adenoma: Systematic review. Int J Surg. 2015;19:137–45.
Manucha V, Ioffe OB. Metastasizing pleomorphic adenoma of the salivary gland. Arch Pathol Lab Med. 2008;132(9):1445–7.
Dardick I, et al. Immunohistochemical and ultrastructural correlates of muscle-actin expression in pleomorphic adenomas and myoepitheliomas based on comparison of formalin and methanol fixation. Virchows Arch A Pathol Anat Histopathol. 1992;421(2):95–104.
Simpson RH, Jones H, Beasley P. Benign myoepithelioma of the salivary glands: a true entity? Histopathology. 1995;27(1):1–9.
Turgut S, et al. Myoepithelioma of the parotid gland: a report of two cases. Ear Nose Throat J. 2001;80(3):155–8.
Hyman BA, et al. Membranous basal cell adenoma of the parotid gland. Malignant transformation in a patient with multiple dermal cylindromas. Arch Pathol Lab Med. 1988;112(2):209–11.
Scott AR, Faquin WC, Deschler DG. Parotid mass in a woman with multiple cutaneous cylindromas. Head Neck. 2010;32(5):684–7.
Yu GY, Ubmuller J, Donath K. Membranous basal cell adenoma of the salivary gland: a clinicopathologic study of 12 cases. Acta Otolaryngol. 1998;118(4):588–93.
Deutsch E, et al. Synchronous bilateral oncocytoma of the parotid glands. A case report. ORL J Otorhinolaryngol Relat Spec. 1984;46(2):66–8.
Sorensen M, et al. Multifocal adenomatous oncocytic hyperplasia of the parotid gland (unusual clear cell variant in two female siblings.). Pathol Res Pract. 1986;181(2):254–9.
Hyde J, et al. Bilateral multinodular oncocytomas of the parotid arising in a background of bilateral oncocytic nodular hyperplasia. Ear Nose Throat J. 2008;87(1):51–4.
Ellies M, Laskawi R, Arglebe C. Extraglandular Warthin’s tumours: clinical evaluation and long-term follow-up. Br J Oral Maxillofac Surg. 1998;36(1):52–3.
Lam KH, et al. Multifocal nature of adenolymphoma of the parotid. Br J Surg. 1994;81(11):1612–4.
Gnepp DR, Schroeder W, Heffner D. Synchronous tumors arising in a single major salivary gland. Cancer. 1989;63(6):1219–24.
Bastaki JM, et al. Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors. Head Neck Pathol. 2014;8(3):250–60.
Tasaki T, et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the salivary gland: case report and review of the literature. Pathol Int. 2013;63(2):125–31.
Brandwein MS, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25(7):835–45.
McHugh CH, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012;118(16):3928–36.
Pires FR, et al. Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(2):174–80.
Nakayama T, et al. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Mod Pathol. 2009;22(12):1575–81.
Jee KJ, et al. Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma. Mod Pathol. 2013;26(2):213–22.
Shinawi T, et al. KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia. Epigenetics. 2012;7(3):211–5.
Ellington CL, et al. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer. 2012;118(18):4444–51.
Dal Maso M, Lippi L. Adenoid cystic carcinoma of the head and neck: a clinical study of 37 cases. Laryngoscope. 1985;95(2):177–81.
Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg. 1974;128(4):512–20.
Nagao T. “Dedifferentiation” and high-grade transformation in salivary gland carcinomas. Head Neck Pathol. 2013;7(Suppl 1):S37–47.
Brayer KJ, et al. Recurrent fusions in MYB and MYBL1 define a common, transcription factor-driven oncogenic pathway in salivary gland adenoid cystic carcinoma. Cancer Discov. 2016;6(2):176–87.
Persson M, et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A. 2009;106(44):18740–4.
Nordkvist A, et al. Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosomes Cancer. 1994;10(2):115–21.
van Weert S, et al. Histopathological grading of adenoid cystic carcinoma of the head and neck: analysis of currently used grading systems and proposal for a simplified grading scheme. Oral Oncol. 2015;51(1):71–6.
Szanto PA, et al. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54(6):1062–9.
Rettig EM, et al. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma. Laryngoscope. 2015;125(9):E292–9.
Jayaprakash V, et al. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: analysis of 228 cases from the surveillance, epidemiology, and end results database. Head Neck. 2014;36(5):694–701.
LiVolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer. 1977;39(5):2209–30.
Katabi N, et al. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol. 2015;46(1):26–33.
Weiler C, et al. Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases. Histopathology. 2011;59(4):741–50.
Griffith CC, et al. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma. Histopathology. 2014;65(6):854–60.
Di Palma S, et al. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Histopathology. 2005;46(2):144–52.
Jaehne M, et al. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer. 2005;103(12):2526–33.
Locati LD, et al. Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers. Head Neck. 2016;38(5):724–31.
Masubuchi T, et al. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma. Int J Clin Oncol. 2015;20(1):35–44.
Di Palma S, et al. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes. Histopathology. 2012;61(4):629–43.
Kapadia SB, Barnes L. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol. 1998;11(11):1033–8.
Williams L, et al. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression. Am J Surg Pathol. 2015;39(5):705–13.
Mitani Y, et al. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014;20(24):6570–81.
Saintigny P, et al. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: implications for targeted therapy. Cancer. 2018;124(18):3693–705.
Kimple AJ, et al. Polymorphous low-grade adenocarcinoma: a case series and determination of recurrence. Laryngoscope. 2014;124(12):2714–9.
Castle JT, et al. Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer. 1999;86(2):207–19.
Patel TD, et al. Polymorphous low-grade adenocarcinoma of the head and neck: a population-based study of 460 cases. Laryngoscope. 2015;125(7):1644–9.
Michal M, et al. Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology. 1999;35(6):495–501.
Simpson RH, et al. Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma. Histopathology. 2002;41(3):250–9.
Klijanienko J, Vielh P. Cytologic characteristics and histomorphologic correlations of 21 salivary duct carcinomas. Diagn Cytopathol. 1998;19(5):333–7.
Patel NR, et al. Demographic trends and disease-specific survival in salivary acinic cell carcinoma: an analysis of 1129 cases. Laryngoscope. 2014;124(1):172–8.
Chiosea SI, et al. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol. 2012;36(3):343–50.
Spiro RH, Huvos AG, Strong EW. Acinic cell carcinoma of salivary origin. A clinicopathologic study of 67 cases. Cancer. 1978;41(3):924–35.
Skalova A, et al. Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes. Am J Surg Pathol. 2009;33(8):1137–45.
Thompson LD, et al. Clinicopathologic and immunophenotypic characterization of 25 cases of acinic cell carcinoma with high-grade transformation. Head Neck Pathol. 2016;10(2):152–60.
Reis-Filho JS, et al. Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probes. Histopathology. 2008;52(7):840–6.
Skalova A, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599–608.
Ito Y, et al. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion. Am J Surg Pathol. 2015;39(5):602–10.
Sethi R, et al. Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy. Laryngoscope. 2014;124(1):188–95.
Skalova A, et al. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes. Am J Surg Pathol. 2014;38(1):23–33.
Majewska H, et al. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement. Virchows Arch. 2015;466(3):245–54.
Wahlberg P, et al. Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients. Oral Oncol. 2002;38(7):706–13.
Whittaker JS, Turner EP. Papillary tumours of the minor salivary glands. J Clin Pathol. 1976;29(9):795–805.
Gillenwater AM, et al. Primary intestinal-like adenocarcinoma of major salivary glands: 2 instances of previously undocumented phenotype. Head Neck. 2013;35(8):E234–6.
Slova D, et al. Colonic-type adenocarcinoma of the base of the tongue: a case report of a rare neoplasm. Head Neck Pathol. 2012;6(2):250–4.
Ellis GL, Wiscovitch JG. Basal cell adenocarcinomas of the major salivary glands. Oral Surg Oral Med Oral Pathol. 1990;69(4):461–9.
Choi HR, et al. Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma? Am J Surg Pathol. 2002;26(6):778–83.
Rito M, et al. Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression. Mod Pathol. 2018;31(7):1064–72.
Milchgrub S, et al. Hyalinizing clear cell carcinoma of salivary gland. Am J Surg Pathol. 1994;18(1):74–82.
Solar AA, Schmidt BL, Jordan RC. Hyalinizing clear cell carcinoma: case series and comprehensive review of the literature. Cancer. 2009;115(1):75–83.
Tanguay J, Weinreb I. What the EWSR1-ATF1 fusion has taught us about hyalinizing clear cell carcinoma. Head Neck Pathol. 2013;7(1):28–34.
Shah AA, et al. EWSR1 genetic rearrangements in salivary gland tumors: a specific and very common feature of hyalinizing clear cell carcinoma. Am J Surg Pathol. 2013;37(4):571–8.
Batsakis JG, Luna MA, el-Naggar A. Histopathologic grading of salivary gland neoplasms: III. Adenoid cystic carcinomas. Ann Otol Rhinol Laryngol. 1990;99(12):1007–9.
Gnepp DR. Mucinous myoepithelioma, a recently described new myoepithelioma variant. Head Neck Pathol. 2013;7(Suppl 1):S85–9.
Skalova A, et al. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component. Am J Surg Pathol. 2015;39(3):338–48.
Kong M, et al. Prognostic factors in myoepithelial carcinoma of salivary glands: a clinicopathologic study of 48 cases. Am J Surg Pathol. 2015;39(7):931–8.
Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol. 2007;31(1):44–57.
Seethala RR. Oncocytic and apocrine epithelial myoepithelial carcinoma: novel variants of a challenging tumor. Head Neck Pathol. 2013;7(Suppl 1):S77–84.
Roy P, et al. Epithelial-myoepithelial carcinoma with high grade transformation. Am J Surg Pathol. 2010;34(9):1258–65.
Stephen J, et al. True malignant mixed tumors (carcinosarcoma) of salivary glands. Oral Surg Oral Med Oral Pathol. 1986;61(6):597–602.
Kwon MY, Gu M. True malignant mixed tumor (carcinosarcoma) of parotid gland with unusual mesenchymal component: a case report and review of the literature. Arch Pathol Lab Med. 2001;125(6):812–5.
Love GL, Sarma DP. Spindle cell mucoepidermoid carcinoma of submandibular gland. J Surg Oncol. 1986;31(1):66–8.
Manuel S, et al. Carcinosarcoma of the parotid gland with epithelial-myoepithelial carcinoma and pleomorphic sarcoma components. Br J Oral Maxillofac Surg. 2002;40(6):480–3.
Kawaratani H, et al. Large cell neuroendocrine carcinoma presenting with neck swelling in the submandibular gland: a case report. J Med Case Rep. 2013;7(1):81.
Walters DM, et al. Small cell carcinoma of the submandibular gland: a rare small round blue cell tumor. Am J Otolaryngol. 2007;28(2):118–21.
Pang B, et al. Desmoplastic small round cell tumor of major salivary glands: report of 1 case and a review of the literature. Appl Immunohistochem Mol Morphol. 2011;19(1):70–5.
Kuo T, Hsueh C. Lymphoepithelioma-like salivary gland carcinoma in Taiwan: a clinicopathological study of nine cases demonstrating a strong association with Epstein-Barr virus. Histopathology. 1997;31(1):75–82.
Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer. 1992;69(8):2021–30.
Wang CP, et al. Lymphoepithelial carcinoma versus large cell undifferentiated carcinoma of the major salivary glands. Cancer. 2004;101(9):2020–7.
Li F, et al. A clinical analysis of 37 cases with lymphoepithelial carcinoma of the major salivary gland treated by surgical resection and postoperative radiotherapy: a single institution study. Med Oncol. 2014;31(5):957.
Gaughan RK, Olsen KD, Lewis JE. Primary squamous cell carcinoma of the parotid gland. Arch Otolaryngol Head Neck Surg. 1992;118(8):798–801.
Marks MW, et al. Squamous cell carcinoma of the parotid gland. Plast Reconstr Surg. 1987;79(4):550–4.
Wang W, Li Y, Tang Y. Keratocystoma of the parotid gland: a case report and review of previous publications. Br J Oral Maxillofac Surg. 2015;53(7):655–7.
Ortiz-Hidalgo C, et al. Sialoblastoma: report of a congenital case with dysembryogenic alterations of the adjacent parotid gland. Histopathology. 2001;38(1):79–80.
Canalis RF, et al. Congenital basal cell adenoma of the submandibular gland. Arch Otolaryngol. 1980;106(5):284–6.
Vawter GF, Tefft M. Congenital tumors of the parotid gland. Arch Pathol. 1966;82(3):242–5.
Taylor GP. Congenital epithelial tumor of the parotid-sialoblastoma. Pediatr Pathol. 1988;8(4):447–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
El-Naggar, A.K. (2019). Management-Based Pathology Assessment of Salivary Gland Carcinomas. In: Licitra, L., Locati, L. (eds) Salivary Gland Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-02958-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-02958-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-02957-9
Online ISBN: 978-3-030-02958-6
eBook Packages: MedicineMedicine (R0)